Literature DB >> 25170199

Genetic variants of innate immune receptors and infections after liver transplantation.

Gemma Sanclemente1, Asuncion Moreno1, Miquel Navasa1, Francisco Lozano1, Carlos Cervera1.   

Abstract

Infection is the leading cause of complication after liver transplantation, causing morbidity and mortality in the first months after surgery. Allograft rejection is mediated through adaptive immunological responses, and thus immunosuppressive therapy is necessary after transplantation. In this setting, the presence of genetic variants of innate immunity receptors may increase the risk of post-transplant infection, in comparison with patients carrying wild-type alleles. Numerous studies have investigated the role of genetic variants of innate immune receptors and the risk of complication after liver transplantation, but their results are discordant. Toll-like receptors and mannose-binding lectin are arguably the most important studied molecules; however, many other receptors could increase the risk of infection after transplantation. In this article, we review the published studies analyzing the impact of genetic variants in the innate immune system on the development of infectious complications after liver transplantation.

Entities:  

Keywords:  Genetic variants; Innate immunity; Liver transplantation; Mannose-binding lectin; Post-transplant infections; Single nucleotide polymorphisms; Toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 25170199      PMCID: PMC4145753          DOI: 10.3748/wjg.v20.i32.11116

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  168 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

Authors:  René Adam; Vincent Karam; Valérie Delvart; John O'Grady; Darius Mirza; Jurgen Klempnauer; Denis Castaing; Peter Neuhaus; Neville Jamieson; Mauro Salizzoni; Stephen Pollard; Jan Lerut; Andreas Paul; Juan Carlos Garcia-Valdecasas; Fernando San Juan Rodríguez; Andrew Burroughs
Journal:  J Hepatol       Date:  2012-05-16       Impact factor: 25.083

3.  Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.

Authors:  Miquel Granell; Alvaro Urbano-Ispizua; Belén Suarez; Montserrat Rovira; Francesc Fernández-Avilés; Carmen Martínez; Mar Ortega; Carla Uriburu; Anna Gaya; Josep M A Roncero; Alfons Navarro; Enric Carreras; Josep Mensa; Jordi Vives; Ciril Rozman; Emili Montserrat; Francisco Lozano
Journal:  Exp Hematol       Date:  2006-10       Impact factor: 3.084

4.  Current concepts on cytomegalovirus infection after liver transplantation.

Authors:  Sang-Oh Lee; Raymund R Razonable
Journal:  World J Hepatol       Date:  2010-09-27

Review 5.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

Review 6.  Risk factors for infection after liver transplantation.

Authors:  Bart van Hoek; Bert-Jan de Rooij; Hein W Verspaget
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-02       Impact factor: 3.043

Review 7.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

Review 8.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

9.  Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection.

Authors:  Mikko Seppänen; Marja-Liisa Lokki; Maija Lappalainen; Eija Hiltunen-Back; Anja T Rovio; Saara Kares; Mikko Hurme; Janne Aittoniemi
Journal:  Hum Immunol       Date:  2009-02-04       Impact factor: 2.850

10.  Characterization and functional investigation of single nucleotide polymorphisms (SNPs) in the human TLR5 gene.

Authors:  Sabine Merx; Wilma Zimmer; Michael Neumaier; Parviz Ahmad-Nejad
Journal:  Hum Mutat       Date:  2006-03       Impact factor: 4.878

View more
  4 in total

1.  Association of TLR3 single nucleotide polymorphisms with susceptibility to HTLV-1 infection in Iranian asymptomatic blood donors.

Authors:  Hossein Mehrabi Habibabadi; Masoud Parsania; Ali Akbar Pourfathollah; Setareh Haghighat; Zohreh Sharifi
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-22       Impact factor: 1.581

2.  Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients.

Authors:  Natalia Redondo; Isabel Rodríguez-Goncer; Patricia Parra; Tamara Ruiz-Merlo; Francisco López-Medrano; Esther González; Natalia Polanco; Hernando Trujillo; Ana Hernández; Rafael San Juan; Amado Andrés; José María Aguado; Mario Fernández-Ruiz
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

3.  Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study.

Authors:  Marta Bodro; Carlos Cervera; Laura Linares; Belén Suárez; Jaume Llopis; Gemma Sanclemente; Sergi Casadó-Llombart; Mario Fernández-Ruiz; María Carmen Fariñas; Sara Cantisan; Miguel Montejo; Elisa Cordero; Isabel Oriol; María Angeles Marcos; Francisco Lozano; Asunción Moreno
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

Review 4.  Toll-Like Receptor 3 is Associated With the Risk of HCV Infection and HBV-Related Diseases.

Authors:  Pei-Liang Geng; Li-Xue Song; Huaijie An; Jing-Yu Huang; Sheng Li; Xian-Tao Zeng
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.